SEMA4F and endometrial cancer: The genes CHRM2, GRIN1, L1CAM, and SEMA4F, which are prognostically associated with endometrial cancer, play important roles in immune cell infiltration, immune response and stem cell relevance, clinical features, enriched pathways, and immunotherapy, and are potential biomarkers for EC with significant clinical translational potential.